American Century Companies Inc Rocket Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$16.78 - $31.94 $140,448 - $267,337
8,370 New
8,370 $250,000
Q1 2021

May 14, 2021
SELL
$43.34 - $65.91 $986,201 - $1.5 Million
-22,755 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$23.3 - $59.57 $530,191 - $1.36 Million
22,755 New
22,755 $1.25 Million

Others Institutions Holding RCKT

# of Institutions
218
Shares Held
93.3M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $783M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email